Marc Becker has more than 20 years of experience in commercial, operational and corporate finance and a deep understanding of the global biopharmaceutical industry. He was previously Chief Financial Officer and Senior Vice President of rEVO Biologics, where he led the finance team in anticipation of raising private and public capital, outlined the market opportunity for the Company and managed its governance and SEC Compliance through S-1 filing and IPO road show. Before that, Marc spent 10 years at Genzyme, most recently serving as Finance Director for the UK and Ireland before returning to the United States to become the Vice President of Finance for the Renal and Endocrine business. He held global P&L responsibility with multiple product lines, large scale, and reimbursement complexity. Marc started his career in auditing and commercial lending for financial services firms, KPMG and BankBoston, and holds a BS from the University of Massachusetts, an MBA from Babson College and was licensed as a CPA.

Pharmaceutical Sciences